Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Development Of Superparamagnetic Nanoparticles For MRI: Effect Of Particle Size, Charge And Surface Nature On Biodistribution.

C. Chouly, D. Pouliquen, I. Lucet, Jean Jacques Le Jeune, P. Jallet
Published 1996 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Twelve superparamagnetic Magnetite-Dextran (MD) nanoparticles potentially useful as contrast agents for Magnetic Resonance Imaging (MRI), with different sizes, charges and surface natures, were produced and internally labelled with (59)Fe in order to investigate the effect of their physicochemical properties on their biodistribution in mice. In a first step, neutral MD particles of a size 33-90.6 nm were studied. Next, the influence of charge was investigated with negative and positive particles (MDL, MDD, MDDEAE). The former (-25, -30 mV) were small, around 30 nm in size whereas the latter (+20 mV) were larger (104 nm). The effect of surface nature was evaluated using MD particles coated with polyoxyethylene-polyoxypropylene copolymers (Synperonic: these MDP particles were neutral and larger in size (65.9-76.4 nm). Experiments showed that 20 min post-injection (2 mg Fe/kg), liver uptake was enhanced when the mean diameter increased: 22% for the smallest and 42% for the largest. It was up to 3 X lower for electrically neutral particles than for charged particles. Coated particles presented higher vascular persistence. The diagnostic potential for liver, lymph node or vascular imaging were discussed.
This paper references
Pharmacokinetic behaviour of charged liposomes in vivo and the influence of charge, lipid composition and pH on electrophoretic mobility in vitro
L. Tan (1990)
10.2214/AJR.152.1.167
Superparamagnetic iron oxide: pharmacokinetics and toxicity.
R. Weissleder (1989)
10.1016/0142-9612(86)90091-8
Phagocytosis of latex particles by leucocytes. I. Dependence of phagocytosis on the size and surface potential of particles.
H. Kawaguchi (1986)
Studies on the relationship between the electrophoretic properties of colloids and their blood clearance and organ distribution in the rat.
D. J. Wilkins (1966)
10.1016/S0006-291X(75)80433-5
The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs.
R. Juliano (1975)
10.1148/RADIOLOGY.162.1.3786766
Ferrite particles: a superparamagnetic MR contrast agent for enhanced detection of liver carcinoma.
S. Saini (1987)
10.1016/0730-725X(91)90412-F
Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism.
D. Pouliquen (1991)
10.1016/0142-9612(88)90033-6
Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage.
Y. Tabata (1988)
10.1148/RADIOLOGY.181.1.1887040
Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging.
R. Weissleder (1991)
10.1016/0014-5793(84)80836-4
The organ uptake of intravenously administered colloidal particles can be altered using a non‐ionic surfactant (Poloxamer 338)
L. Illum (1984)
10.1148/RADIOLOGY.175.2.2326475
Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.
R. Weissleder (1990)
10.1148/RADIOLOGY.178.3.1994416
Asialoglycoprotein receptor function in benign liver disease: evaluation with MR imaging.
P. Reimer (1991)
10.1148/RADIOLOGY.175.2.2326474
Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.
R. Weissleder (1990)
10.1016/S0076-6879(85)12024-0
[22] Dextran and inulin conjugates as drug carriers
L. Molteni (1985)
10.3109/02652049209021219
Influence of the surface properties of low contact angle surfactants on the body distribution of 14C-poly(methyl methacrylate) nanoparticles.
S. Tröster (1992)
10.1016/0378-5173(90)90047-8
Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants
S. Tröster (1990)
10.1002/MRM.1910220251
Blood Clearance of Dextran Magnetite Particles Determined by a noninvasive in vivo ESR method
A. Iannone (1991)
10.1002/MRM.1910240108
Investigation of the magnetic properties of iron oxide nanoparticles used as contrast agent for MRI
D. Pouliquen (1992)
10.1042/BST0170690
Effect of positive charge of liposomes on their clearance from the blood and its relation to vesicle lipid composition
Lloyd Tan (1989)
10.1016/0730-725X(93)90026-A
Liver-directed superparamagnetic iron oxide: quantitation of T2 relaxation effects.
D. Pouliquen (1993)
10.1097/00004424-199002000-00003
Magnetic starch microspheres, efficacy and elimination. A new organ-specific contrast agent for magnetic resonance imaging.
A. K. Fahlvik (1990)
10.1016/0005-2736(84)90521-2
The effects of charge and size on the interaction of unilamellar liposomes with macrophages.
R. Schwendener (1984)
10.1148/RADIOLOGY.169.3.3186986
Quantitation of MR relaxation effects of iron oxide particles in liver and spleen.
S. Majumdar (1988)
10.1016/0378-5173(88)90037-3
Contact angles of surfactants with a potential to alter the body distribution of colloidal drug carriers on poly(methyl methacrylate) surfaces
S. Tröster (1988)
10.3109/02652049209021218
An analysis of first-order release kinetics from albumin microspheres.
J. Okada (1992)



This paper is referenced by
10.2147/IJN.S21019
A single exposure to iron oxide nanoparticles attenuates antigen-specific antibody production and T-cell reactivity in ovalbumin-sensitized BALB/c mice
C. Shen (2011)
Title Preparation and biomedical application of a non-polymer coatedsuperparamagnetic nanoparticle
Lin Du (2009)
Oscillating magnet array-based nanomagnetic gene transfection of mammalian cells relevant to regenerative medicine
A. Fouriki (2017)
10.1002/jmri.20989
Magnetic resonance imaging of vulnerable atherosclerotic plaques: Current imaging strategies and molecular imaging probes
Karen C. Briley-Saebo (2007)
10.1007/978-1-59745-218-2_13
Nano-Sized Carriers for Drug Delivery
S. Sahoo (2008)
10.3390/ma11050779
Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme
L. Nam (2018)
10.2147/IJN.S33120
Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles
F. Roohi (2012)
10.4172/2155-983X.1000115
Diagnostics and Treatment of Metastatic Cancers with Magnetic Nanoparticles
S. Abdeen (2013)
10.1016/j.biomaterials.2011.10.077
ICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance.
S. Crayton (2012)
10.1002/tox.22631
In vitro evaluation of the toxicity and underlying molecular mechanisms of Janus Fe3O4‐TiO2 nanoparticles in human liver cells
H. Su (2018)
10.1016/B978-0-323-41532-3.00014-2
Inorganic nanoflotillas as engineered particles for drug and gene delivery
G. Oza (2016)
10.1155/2014/124236
Novel alginate-gelatin hybrid nanoparticle for drug delivery and tissue engineering applications
E. M. Lee (2014)
10.1039/C3RA40836A
Dextran stabilized lanthanum strontium manganese oxide nanoparticles for magnetic resonance imaging
R. Haghniaz (2013)
10.1186/1477-3155-9-34
Effect of iron oxide and gold nanoparticles on bacterial growth leading towards biological application
S. Chatterjee (2011)
10.1515/bmt-2015-0043
Degradation of magnetic nanoparticles mimicking lysosomal conditions followed by AC susceptibility
L. Gutiérrez (2015)
Development of novel nanomaterials for multimodal biomedical imaging
Lydia Sandiford (2015)
10.1016/j.bbrep.2017.12.002
Comprehensive cytotoxicity studies of superparamagnetic iron oxide nanoparticles
R. Patil (2018)
10.1557/MRS2009.117
Gold-Based Magneto/Optical Nanostructures: Challenges for In Vivo Applications in Cancer Diagnostics and Therapy.
M. Melancon (2009)
10.1007/S11051-011-0580-Z
Biodegradable polymeric nanoformulation based on the antiprotozoal canthin-6-one
J. L. Arias (2011)
10.1007/S11051-009-9749-0
Synthesis of magnetic core–shell Fe3O4–Au nanoparticle for biomolecule immobilization and detection
U. Tamer (2010)
10.1016/S1567-2719(05)16005-3
chapter 5 Synthesis, Properties and Biomedical Applications of Magnetic Nanoparticles
P. Tartaj (2006)
10.1016/S0304-8853(02)01233-7
Magnetostructural study of iron–dextran
F. Lázaro (2003)
10.1007/978-3-030-47120-0
Nanopharmaceuticals: Principles and Applications Vol. 3
V. K. Yata (2020)
10.3109/03602532.2013.876429
Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles
Charlette M. Felton (2014)
10.1006/JCIS.1998.6053
Synthesis of Iron Oxide Nanoparticles Used as MRI Contrast Agents: A Parametric Study.
Babes (1999)
МОРФОЛОГИЧЕСКИЕ ИЗМЕНЕНИЯ В ТКАНЯХ И ОРГАНАХ ЛАБОРАТОРНЫХ КРЫС С ПЕРЕВИВАЕМЫМ РАКОМ ПЕЧЕНИ РС-1 ПРИ ВНУТРИБРЮШИННОМ ВВЕДЕНИИ ЦИТРАТ-СТАБИЛИЗИРОВАННЫХ НАНОЧАСТИЦ ЖЕЛЕЗА
V. I. Razumovsky (2013)
10.1016/j.ijpharm.2018.03.020
IR780 based nanomaterials for cancer imaging and photothermal, photodynamic and combinatorial therapies
Cátia G Alves (2018)
10.1016/j.wneu.2013.01.011
Targeted cell uptake of a noninternalizing antibody through conjugation to iron oxide nanoparticles in primary central nervous system lymphoma.
Tingzhong Wang (2013)
10.2147/NSA.S99986
Synthesis, characterization, applications, and challenges of iron oxide nanoparticles
Attarad Ali (2016)
10.1557/PROC-877-S6.6
Fabrication of Core-shell Type FeCo-Au (Ag) High Moment Magnetic Nanoparticles
J. Bai (2005)
10.1107/S1600577519004909
Reversible rearrangement of magnetic nanoparticles in solution studied using time-resolved SAXS method
Lanqing Huang (2019)
10.4103/0250-474X.36931
Ultrathin Multilayer Capsules in Drug Delivery
A. Jain (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar